Diabetes

The UK Medicines and Healthcare products Regulatory Agency has issued a reminder to patients with diabetes to manage medication appropriately in extreme heat.

A drug that can delay the onset of Type 1 diabetes by an average of nearly three years is to be made available on the NHS, following approval by NICE.

The US FDA has cleared for marketing the first over-the-counter continuous glucose monitor for children.

MHRA approves first GLP-1 weight loss tablet semaglutide for obesity, offering a new oral option for weight management in the UK.

Adults with type 2 diabetes who reported higher anxiety symptoms were more likely to exhibit grazing behaviour and elevated glycated haemoglobin levels, highlighting potential barriers to effective disease management.

Type 2 diabetes is rising twice as fast in women under 40, compared with those over 40, new analysis from Diabetes UK has revealed.

Researchers identified distinct DNA methylation signatures associated with ageing and type 2 diabetes in pancreatic islets, revealing potential biomarkers and therapeutic

Multi-organ biochip grant accepted to explore diabetes-dementia link in patient derived cells.